Market revenue in 2023 | USD 11.3 million |
Market revenue in 2030 | USD 19.2 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | System and Technology Support Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.32% in 2023. Horizon Databook has segmented the Mexico clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
The Mexican clinical trial imaging market is anticipated to grow gradually over the forecast period. This can be attributed to the diverse population in Mexico, which is witnessing an epidemiological shift from diseases typical of less-developed regions to lifestyle-related chronic diseases such as diabetes.
Moreover, physicians in Mexico are extremely specialized, many of them having accomplished training in the U.S. or Europe. In addition, the Federal Commission for Protection against Sanitary Risk (COFEPRIS) issued a list of therapeutic areas of importance for clinical investigation and in the list, cardiovascular diseases, cancer, arthritis, and diabetes are ailments normally observed in the developed world.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into Mexico clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account